159 related articles for article (PubMed ID: 9026656)
1. Novel methods of generating specific oligonucleotide inhibitors of viral polymerases.
Chen H; Brown D; Gold L
Methods Enzymol; 1996; 275():503-20. PubMed ID: 9026656
[No Abstract] [Full Text] [Related]
2. Towards the selection of phosphorothioate aptamers optimizing in vitro selection steps with phosphorothioate nucleotides.
Andreola ML; Calmels C; Michel J; Toulmé JJ; Litvak S
Eur J Biochem; 2000 Aug; 267(16):5032-40. PubMed ID: 10931185
[TBL] [Abstract][Full Text] [Related]
3. Preparation and use of synthetic oligoribonucleotides as tools for study of viral polymerases.
Carroll SS; Benseler F; Olsen DB
Methods Enzymol; 1996; 275():365-82. PubMed ID: 9026650
[No Abstract] [Full Text] [Related]
4. Inhibition of viral polymerases by chain-terminating substrates: a kinetic analysis.
Wilson JE; Porter DJ; Reardon JE
Methods Enzymol; 1996; 275():398-424. PubMed ID: 9026652
[No Abstract] [Full Text] [Related]
5. Mode of inhibition of HIV-1 reverse transcriptase by polyacetylenetriol, a novel inhibitor of RNA- and DNA-directed DNA polymerases.
Loya S; Rudi A; Kashman Y; Hizi A
Biochem J; 2002 Mar; 362(Pt 3):685-92. PubMed ID: 11879196
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory RNA ligand to reverse transcriptase from feline immunodeficiency virus.
Chen H; McBroom DG; Zhu YQ; Gold L; North TW
Biochemistry; 1996 May; 35(21):6923-30. PubMed ID: 8639644
[TBL] [Abstract][Full Text] [Related]
7. Analysis of inhibition of retroviral reverse transcriptase.
Balzarini J; De Clercq E
Methods Enzymol; 1996; 275():472-502. PubMed ID: 9026655
[No Abstract] [Full Text] [Related]
8. High-affinity ssDNA inhibitors of the reverse transcriptase of type 1 human immunodeficiency virus.
Schneider DJ; Feigon J; Hostomsky Z; Gold L
Biochemistry; 1995 Jul; 34(29):9599-610. PubMed ID: 7542922
[TBL] [Abstract][Full Text] [Related]
9. Recognition by viral and cellular DNA polymerases of nucleosides bearing bases with nonstandard hydrogen bonding patterns.
Horlacher J; Hottiger M; Podust VN; Hübscher U; Benner SA
Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6329-33. PubMed ID: 7541538
[TBL] [Abstract][Full Text] [Related]
10. Insights into DNA polymerization mechanisms from structure and function analysis of HIV-1 reverse transcriptase.
Patel PH; Jacobo-Molina A; Ding J; Tantillo C; Clark AD; Raag R; Nanni RG; Hughes SH; Arnold E
Biochemistry; 1995 Apr; 34(16):5351-63. PubMed ID: 7537090
[TBL] [Abstract][Full Text] [Related]
11. Analysis of resistance mutants of viral polymerases.
Oxford JS; al-Jabri AA; Stein CA; Levantis P
Methods Enzymol; 1996; 275():555-600. PubMed ID: 9026659
[No Abstract] [Full Text] [Related]
12. Synthesis and biological activity of 2',5'-oligoadenylate trimers containing 5'-terminal 5'-amino-5'-deoxy- and 5'-amino-3',5'-dideoxyadenosine derivatives.
Kvasyuk EI; Mikhailopulo IA; Suhadolnik RJ; Henderson EE; Muto NF; Iacono KT; Homon J; Pfleiderer W
Nucleosides Nucleotides; 1999; 18(6-7):1483-4. PubMed ID: 10474228
[TBL] [Abstract][Full Text] [Related]
13. Crystallization of human immunodeficiency virus type 1 reverse transcriptase with and without nucleic acid substrates, inhibitors, and an antibody Fab fragment.
Clark AD; Jacobo-Molina A; Clark P; Hughes SH; Arnold E
Methods Enzymol; 1995; 262():171-85. PubMed ID: 8594346
[No Abstract] [Full Text] [Related]
14. Quinoxapeptins: novel chromodepsipeptide inhibitors of HIV-1 and HIV-2 reverse transcriptase. I. The producing organism and biological activity.
Lingham RB; Hsu AH; O'Brien JA; Sigmund JM; Sanchez M; Gagliardi MM; Heimbuch BK; Genilloud O; Martin I; Diez MT; Hirsch CF; Zink DL; Liesch JM; Koch GE; Gartner SE; Garrity GM; Tsou NN; Salituro GM
J Antibiot (Tokyo); 1996 Mar; 49(3):253-9. PubMed ID: 8626240
[TBL] [Abstract][Full Text] [Related]
15. Bent pseudoknots and novel RNA inhibitors of type 1 human immunodeficiency virus (HIV-1) reverse transcriptase.
Burke DH; Scates L; Andrews K; Gold L
J Mol Biol; 1996 Dec; 264(4):650-66. PubMed ID: 8980676
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive chemical modification interference and nucleotide substitution analysis of an RNA pseudoknot inhibitor to HIV-1 reverse transcriptase.
Green L; Waugh S; Binkley JP; Hostomska Z; Hostomsky Z; Tuerk C
J Mol Biol; 1995 Mar; 247(1):60-8. PubMed ID: 7534830
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human immunodeficiency virus type 1 reverse transcriptase by 3'-blocked oligonucleotide primers.
Austermann S; Kruhøffer M; Grosse F
Biochem Pharmacol; 1992 Jun; 43(12):2581-9. PubMed ID: 1378738
[TBL] [Abstract][Full Text] [Related]
18. An unusual "senseless" 2',5'-oligoribonucleotide with potent anti-HIV activity.
Aboul-Fadl T; Agrawal VK; Buckheit RW; Broom AD
Nucleosides Nucleotides Nucleic Acids; 2004; 23(3):545-54. PubMed ID: 15113022
[TBL] [Abstract][Full Text] [Related]
19. Template recognition by an RNA-dependent RNA polymerase: identification and characterization of two RNA binding sites on Q beta replicase.
Brown D; Gold L
Biochemistry; 1995 Nov; 34(45):14765-74. PubMed ID: 7578085
[TBL] [Abstract][Full Text] [Related]
20. Non-nucleoside anti-HIV-1 reverse transcriptase inhibitors (NNRTIs): a chemical survey from lead compounds to selected drugs for clinical trials.
Artico M
Farmaco; 1996 May; 51(5):305-31. PubMed ID: 8767842
[No Abstract] [Full Text] [Related]
[Next] [New Search]
